US Stocks
/
MoonLake Immunotherapeutics Class A Share Price

MoonLake Immunotherapeutics Class A Share Price

NASDAQ: MLTX | Small Cap
$10.83
+$0.24 (2.27%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MoonLake Immunotherapeutics Class A Stock Performance

Open
$10.46
Prev. Close
$10.59
Circuit Range
N/A
Day Range
$10.46 - $11.09
Year Range
$8.82 - $23.25
Volume
1,85,703
Average Traded
$10.60

MoonLake Immunotherapeutics Class A Share Price Today

As of 11 October 2026, MoonLake Immunotherapeutics Class A's share price is $10.83. The stock opened at $10.46, compared to its previous close of $10.59. During today's trading session, MoonLake Immunotherapeutics Class A's share price traded between $10.46 and $11.09, with an average price of $10.77. Over the past 52 weeks, the stock has recorded a high of $23.25 and a low of $8.82. In terms of performance, MoonLake Immunotherapeutics Class A's share price has declined by 33.72% over the last six months and is up 7.55% on a year-on-year basis.

MoonLake Immunotherapeutics Class A Share Price Chart

$10.46$11.09
L
Show Current Price
H

MoonLake Immunotherapeutics Class A Stock Fundamentals & Key Indicators

Market Cap
$698.14M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.08
Revenue (TTM)
$0.00
Return On Equity (TTM)
-61.24%
Profit Margin
N/A
Debt to Equity
0.23
Quarterly Earnings Growth YoY
12.56%

MoonLake Immunotherapeutics Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$70.69-$60.02-$69.71-$61.81
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A15.09%-16.14%11.33%

MoonLake Immunotherapeutics Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$49.97-$36.01-$118.94-$227.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A27.94%-230.30%-91.12%

About MoonLake Immunotherapeutics Class A

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

MoonLake Immunotherapeutics Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$11.69
$10.82
-7.68%
Sep 2026
$15.05
$11.72
-24.55%
Aug 2026
$18.37
$15.54
-15.75%
Jul 2026
$19.75
$18.45
-5.26%
Jun 2026
$18.91
$19.47
+1.54%
May 2026
$16.37
$19.18
+17.35%
Apr 2026
$17.29
$16.34
-12.29%
Mar 2026
$17.29
$18.63
+6.34%
Feb 2026
$16.35
$17.52
+11.84%
Jan 2026
$13.19
$15.66
+18.99%
Dec 2025
$13.59
$13.16
-4.25%
Nov 2025
$10.37
$13.75
+36.54%

MLTX Share Price FAQs

What is MoonLake Immunotherapeutics Class A share price today?

chevron-up
MoonLake Immunotherapeutics Class A share price today is $10.83 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of MoonLake Immunotherapeutics Class A stock?

chevron-up
The 52 week high of MoonLake Immunotherapeutics Class A stock is $23.25, while the 52 week low is $8.82 as of 10 Oct '26.

What is MLTX's market capitalisation today?

chevron-up
MLTX market capitalisation is $698.14M as of October 11, 2026, at 2:05 am IST.

What is MLTX's net income for the last quarter?

chevron-up
MLTX's net income for the last quarter is -61.81B USD.

What is the 5 year returns of MLTX?

chevron-up
The 5 year returns of MLTX is 8.30% as on 10 Oct '26.

What is the high & low stock price of MLTX today?

chevron-up
MLTX stock price hit a high of $11.09 and low of $10.46 as of 10 Oct '26.

Can I buy MLTX shares in India?

chevron-up
Yes. You can buy MLTX in India by opening an international trading account.